StonvexLoading…
StonvexStonvexStonvexCore line items from PCOR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.32B | $1.15B | $950.01M | $720.20M |
Operating Income | $-124.34M | $-136.42M | $-215.68M | $-290.45M |
Net Income | $-100.78M | $-105.96M | $-189.69M | $-286.93M |
EPS (Diluted) | $-0.67 | $-0.72 | $-1.34 | $-2.10 |
Total Assets | $2.24B | $2.10B | $1.89B | $1.74B |
Total Liabilities | $976.80M | $813.02M | $737.96M | $623.63M |
Cash & Equivalents | $480.68M | $437.72M | $357.79M | $296.71M |
Free Cash Flow OCF − CapEx | $282.17M | $177.03M | $81.69M | $-3.17M |
Shares Outstanding | 151.71M | 149.85M | 144.81M | 139.16M |